Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

EVEROLIMUS-ELUTING (XIENCE V) STENTS VERSUS SIROLIMUS-ELUTING (CYPHER) STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL

(2010) Robert A. Byrne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2-Year Clinical and Angiographic Outcomes From a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents Versus Polymer-Based Cypher and Endeavor, Drug-Eluting Stents

(2010) Robert A. Byrne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation

(2010) Cheol Whan Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

(2010) Elvin Kedhi et al.   LANCET

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

(2010) Klaus Rasmussen et al.   LANCET

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2010) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Contact activation of blood-plasma coagulation

(2009) Erwin A. Vogler et al.   BIOMATERIALS

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis

(2009) A. K. M. Hassan et al.   EUROPEAN HEART JOURNAL

Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs

(2009) Mark Y. Chan et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden

(2009) Stefan K. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations

(2009) Vijaya B. Kolachalama et al.   PLoS One

A Clinical Risk Score for Prediction of Stent Thrombosis

(2008) Kenneth W. Baran et al.   AMERICAN JOURNAL OF CARDIOLOGY

On the mechanisms of biocompatibility

(2008) David F. Williams   BIOMATERIALS

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION

High Incidence of Intramural Thrombus After Overlapping Paclitaxel-Eluting Stent Implantation

(2008) Toshiro Shinke et al.   Circulation-Cardiovascular Interventions

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents

(2008) P. Roy et al.   EUROPEAN HEART JOURNAL

The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography

(2008) Jun Tanigawa et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Luminal flow patterns dictate arterial drug deposition in stent-based delivery

(2008) Vijaya B. Kolachalama et al.   JOURNAL OF CONTROLLED RELEASE

A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications

(2008) Oscar C. Marroquin et al.   NEW ENGLAND JOURNAL OF MEDICINE